1. 43 THE ROLE OF PROTEIN PHOSPHATASE 2A IN THE REGULATION OF ENDOTHELIAL CELL CYTOSKELETON STRUCTURE. (1st March 2006) Authors: Tar, K.; Csortos, C.; Czikora, I.; Olah, G.; Ma, S-F.; Wadgaonkar, R.; Gergely, P.; Garcia, J. G.N.; Verin, A. D. Journal: Journal of investigative medicine Issue: Volume 54:Number 2(2006) Page Start: S350 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0632 Essdai domain evaluation of primary sjÖgren's syndrome (PSS) patients enrolled in two independent poc studies indicates differential utility of domains for trial inclusion and composite endpoints in pss trials. (12th June 2018) Authors: Dörner, T.; Fisher, B.A.; Ren, X.; Faerber, P.; Gergely, P.; Mooney, L.; Li, Y.; Oliver, S.J.; Hueber, W.; Wright, A.M. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0230 Assessment of Safety, Pharmacokinetics and Pharmacodynamics of A Novel anti-CD40 Monoclonal antibody, CFZ533, in Healthy Volunteers and in Rheumatoid Arthritis Patients. (15th July 2016) Authors: Slade, A.; Koo, P.; He, Y.; Espie, P.; Auger-Sarrazin, A.; Rush, J.; Gergely, P. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 516 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OP0250 A randomised, double-blind study to assess the safety, tolerability and preliminary efficacy of leniolisib (CDZ173) in patients with primary sjÖgren's syndrome. (12th June 2018) Authors: Dörner, T.; Zeher, M.; Laessing, U.; Chaperon, F.; De Buck, S.; Hasselberg, A.; Valentin, M.-A.; Ma, S.; Cabanski, M.; Kalis, C.; Burkhart, C.; Gergely, P. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 174 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Primary alterations during the development of hidradenitis suppurativa. (26th November 2021) Authors: Dajnoki, Z.; Somogyi, O.; Medgyesi, B.; Jenei, A.; Szabó, L.; Gáspár, K.; Hendrik, Z.; Gergely, P.; Imre, D.; Póliska, S.; Törőcsik, D.; Zouboulis, C.C.; Prens, E.P.; Kapitány, A.; Szegedi, A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 3(2022) Page Start: 462 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗